scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.38) by 2.63 percent. This is a 54.17 percent decrease over losses of $(0.24) per share from the same period last year.
BMO Capital Upgrades Element Fleet Management to Outperform, Raises Price Target to C$19
BMO Capital analyst Tom MacKinnon upgrades Element Fleet Management (TSX:EFN) from Market Perform to Outperform and raises the price target from C$13.5 to C$19.